SCHEMBL20799115

SCHEMBL20799115

Cc1ccc(NC(=O)N2CCN(c3ncnc4[nH]c(-c5ccncc5)cc34)CC2)cn1

nearest known ligand 0.76

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KIT P10721 20/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15664443 0.86 KIT (1.00) KIT
SCHEMBL15664789 0.86 KIT (1.00) KIT
SCHEMBL20799059 0.86 KIT (0.75) KIT
SCHEMBL20799061 0.85 KIT (0.78) KIT
SCHEMBL20799000 0.82 KIT (0.75) KIT
SCHEMBL15664117 0.81 KIT (1.00) KIT
SCHEMBL15664264 0.81 KIT (1.00) KIT
SCHEMBL15664562 0.79 KIT (1.00) KIT
SCHEMBL15664496 0.79 KIT (1.00) KIT
SCHEMBL15664338 0.79 KIT (1.00) KIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10227357-B2 Compounds and methods for kinase modulation, and indications therefor PLEXXIKON INC. (US) 2019-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10227357-B2 Compounds and methods for kinase modulation, and indications therefor KIT, PRKCH, PRKACA KIT 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.